Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

NCT05546853 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05546853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05546853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Lead sponsor
University Hospital, Grenoble
Phase
Phase 1
Overall status
Completed
Start date
March 28, 2023
Completion date
June 16, 2025
Enrollment
43 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma